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Abstract 
The goal of genome-wide association studies (GWASs) is to discover genetic variants associated with 
diseases/traits. Replication is a common validation method in GWASs. We regard an association as true 
finding when it shows significance in both primary and replication studies. A question worth pondering is 
what is the probability of a primary association (i.e., a statistically significant association in the primary 
study) being validated in the replication study? This paper systematically reviews the answers to this 
question from different points of view. Since Bayesian methods can help us integrate out the uncertainty 
about the underlying effect of the primary association, we will mainly focus on the Bayesian view in this 
paper. We refer the Bayesian replication probability as the replication rate (RR). We further describe an 
estimation method for RR which makes use of the summary statistics from the primary study. We can use 
the estimated RR to determine the sample size of the replication study and to check the consistency between 
the results of the primary study and those of the replication study. We describe an R-package to estimate 
and apply RR in GWASs. Simulation and real data experiments show that the estimated RR has good 
prediction and calibration performance. We also use these data to demonstrate the usefulness of RR. The 
R-package is available at http://bioinformatics.ust.hk/RRate.html. 
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1  Introduction 
The goal of genome-wide association studies (GWASs) is to detect genetic variants associated with 
diseases/traits by genotyping single nucleotide polymorphisms (SNPs) in different individuals [1]. 
Compared to traditional candidate gene studies based on gene function and pathway information [2], 
GWASs avoid selection bias by genotyping a dense set of SNPs across the whole genome. Also, GWASs 
are more powerful than linkage analysis in detecting genetic variants contributing to disease risk with 
modest effect [3]. Since the first GWAS on age-related macular degeneration (AMD) [4], there have been 
about 2000 GWASs reported so far, with 14609 associations showing genome-wide significance (p-value
85 10  ) for 756 different diseases/traits [5]. 
Replication is a commonly used validation method in scientific discoveries [6, 7]. We commonly call a 
study used for discovery “the primary study” and a study used for validation “the replication study”. In 
GWASs, we regard an association as a true finding with high confidence when it shows significance in both 
the primary and replication studies [8, 9]. Suppose the type I error rates in the primary study and the 
replication study are 1  and 2 , respectively. The probability of observing more extreme statistics is 
below 1 212   when the association doesn’t exist. (We have the factor 
1
2  here because only the 
associations showing significance in the same direction in both the primary and replication studies are 
replicated.) Since this is a very low probability, there is a high confidence that the replicable association is 
a true finding. 
Even when a primary association (i.e., statistically significant association in the primary study) is true, 
it is only replicated with a certain probability. This is because the strengths of associations are subject to 
random variability due to random sampling, confounding effects and measurement errors [10]. Given 
information from the primary study, researchers would like to know how probable it is that a primary 
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association will be validated in the replication study. To answer this question, we need a systematic study 
of the behavior of primary associations in replication studies. 
Recently, Science published an open empirical study of reproducibility in psychology, called the 
Reproducibility Project [11]. Researchers tried to replicate one hundred empirical studies from three top 
psychology journals using high-powered designs, but only thirty six of them had significant results (p-
value≤0.05). This “replication crisis” has highly stressed the importance of studying the probability of 
replicating a significant association in different disciplines. Currently, there is few research to quantify 
replication probability of a significant association. Jaffe et al. (2013) [12] gives an example to estimate the 
probability of replicating results in a gene-set analyses using bootstrap method. 
The aim of this paper is to systematically study primary positives in the replication study setting of 
GWASs and to review answers to the replication question from different points of view. Since Bayesian 
methods can help us integrate out the uncertainty about the underlying effect of the primary association, we 
will mainly focus on the Bayesian view in this paper. We refer the Bayesian replication probability as the 
replication rate (RR). We further describe an estimation method for RR when the summary statistics of the 
primary study are available. We demonstrate the two applications of RR:  
1. To determine the sample size of the replication study (i.e., how many individuals are needed in the 
replication study to achieve a certain probability of replicating primary associations?).  
2. To check the consistency between the results of the primary study and those of the replication study 
(i.e., are the results of the replication study consistent with RR values estimated from the primary 
study?). We use the Hosmer-Lemeshow test [13] in this application.  
The rest of this paper is organized as follows. In the next section, we will first review the answers to the 
replication question from the frequentist and Bayesian view. Then we will give the mathematical definitions 
of RR. We will also derive the relationship among the local false discovery rate (lfdr) [14], power and RR. 
In Section 3, we will describe how to estimate RR using the Bayesian framework with a two-component 
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mixture prior. In Section 4, We will show the two applications of RR. In Section 5, we will describe an R-
package to estimate and apply RR in GWASs. In Section 6, we will first use simulation experiments to 
illustrate that the estimated RR has good prediction and calibration performance when data agree with model 
assumptions. Then we will show the empirical results using type 2 diabetes (T2D) data from the DIAbetes 
Genetics Replication And Meta-analysis (DIAGRAM) consortium [15] and total cholesterol (TC) data from 
the Global Lipids Genetics Consortium (GLGC) [16]. The experiments also demonstrate the usefulness of 
RR. In Section 7, we will discuss the limitations of current modeling and estimation method, and these 
provide guidance for the future work. Section 8 concludes the paper. 
2  Definition of RR 
As an illustration, we use a log(OR) test to identify associations. Here log(OR) stands for the logarithm of 
the odds ratio. We can easily generalize the model to quantitative traits with simple linear regression. In 
Section 6, we give an example of RR estimation for GWASs with a quantitative trait. 
Let’s assume study j (j=1,2 denoting primary study and replication study, respectively) has ( )jn  
individuals, where ( )0 jn  of them are controls and ( )1 jn  are cases. The number of SNPs is m. We use 0  
to denote the proportion of null SNPs, which have no association with the disease. 
For each SNP, we use A to represent the non-effect allele and a to denote the effect allele. Table 1 shows 
a contingency table of alleles. Using the contingency table, we can estimate the logarithm of the odds ratio:  
 ( ) ( ) ( ) ( ) ( )00 01 10 11ˆ log log log log .j j j j jn n n n       (1) 
The true effect size   is ordinarily unknown. Using Woolf’s method [17], we can approximate the 
asymptotic standard error of ( )ˆ j  (denoted as ( )j ) as follows:  
 ( ) ( ) ( ) ( ) ( )
00 01 10 11
1 1 1 1 .j j j j jn n n n       (2) 
7 
 
The null and alternative hypotheses are  
 0 1: 0,  vs. : 0,      (3) 
and the corresponding test statistic is ( ) ( ) ( )ˆ /j j jz   . Let’s assume the significance levels in the two 
studies are 1  and 2 , respectively. 
Since we use a two-sided test in the primary study, a SNP showing an association with the disease has 
an absolute value of its z-value that is larger than 
1 /2z , i.e., 1(1) /2| |z z , where uz  is the upper u quantile 
of the standard normal distribution (0≤u≤0.5). For the association validated in the replication study, the z-
value should be consistent with the z-value in the primary study. Thus, (2)z  should have the same sign as 
(1)z  and should also be larger than 
2 /2z  in terms of absolute value, i.e., 2(1) (2) /2( )sgn z z z , where the 
sign function reads  
 
1 if x 0
( ) 0 if x=0 .
1 if x 0
sgn x
  
  (4) 
We assume the replication study is collected independently of the primary study. For a significant 
association in the primary study (i.e., 1(1) /2| |z z ), we want to know what is the probability of it being 
validated in the replication study? 
From a frequentist point of view, this replication probability is the proportion of this primary association 
being validated in multiple independent replication studies with the same setting. If the primary association 
is a false positive, the replication probability is just the type I error rate 2 / 2 . If the primary association 
is a true finding, then the replication probability is the power of replicating this association, which depends 
on the true effect size μ. The definition of replication power is  
 
2
(2) (1) (2) (1)
/2( ) ( ( ) , ).|P sgn z Z z z      (5) 
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We do not know whether the primary association is a true finding or not, and we also do not know what the 
true effect size is if it is a true finding. In other words, there is uncertainty in answering our major question 
with the frequentist replication probability. 
For this reason, we will focus on the Bayesian replication probability RR. We define RR as  
 
2
(1) (2) (1)
/2RR ( ( ) ),|P sgn z Z z z    (6) 
which removes the dependence of the replication probability on the underlying true status and effect size of 
the primary association. We can view RR as the estimator of the frequentist replication probability in terms 
of minimizing the Bayes risk. 
We derive the relationship among the local false discovery rate of the primary study (1)lfdr , the power 
of the replication study (2) ( )   and the RR using Bayes’ formula (details are in the Supplementary Notes):  
 (1) (1) (2)2RR lfdr ( / 2) (1 lfdr ) ,      (7) 
where (1) (1)0lfdr ( )|P z  , and 2(2) (1) (2) (1) (2) (1)/2 1 1( ( ) , ) ( ( ) , )| |P sgn z Z z z E z       is the 
Bayesian predictive power [18] of the replication study. The Bayesian predictive power (2)  averages the 
power (2) ( )   among all possible effect size values given the test statistics in the primary study. 
We can regard RR as a weighted average between the true null component 2 / 2  and the true 
associated component (2) , where (1)lfdr  and (1)1-lfdr  are the weights, respectively. Thus, we can 
calculate RR once (1)lfdr  and (2)  are known. 
Both (1)lfdr  and (2)  are the posterior probabilities which depend on the distribution of the 
underlying true effect size value  . We need to specify a prior distribution of μ for the calculation of 
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(1)lfdr  and (2) . In the following section, we will use a two-component mixture prior for   to derive 
their calculation formulas. 
3  Estimation of RR 
In each study, the log(OR) estimator ( )ˆ j  is asymptotically normally distributed with a mean   and a 
standard deviation ( )j , i.e.,  
 
( )
( )
ˆ ~ (0,1).
j
j N
 

   (8) 
The true effect size   is unknown. Research on heritability decomposition [19] and effect size 
distribution [20] suggests that SNPs with small effect sizes occupy a larger proportion of the associated 
SNPs than those with large effect sizes. Hence, a natural prior for the effect size of the associated SNPs is 
a Gaussian prior with mean zero. Since we don’t know whether an arbitrary SNP is associated or not, we 
use the following two-component mixture prior for all SNPs:  
 20 0 0 0~ (1 ) (0, ),N        (9) 
where 0  is the distribution with point mass on zero whose probability density function (pdf) is Dirac 
function ( )x . 
With this prior, we have (1) 20(1)~ (0,1 ( ) )Z N   under 1 . Since 
(1) ~ (0,1)Z N  under 0 , we 
can derive the local false discovery rate of the primary study according to Bayes’ rule:  
 
(1)
0 0
0 0 1
(1)
(1) (1)
(1)
0
1
(1)
(1)
0 0 (1) 2
0
|
| ) |
P( ) ( )lfdr P( ) ( ) P( ( )
( )= ,
( ) 1- ( )1) ( / )
p z
p z p z
z
zz
 
     
 
 （
 
   
  (10) 
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where ( )x  is the pdf of the standard normal distribution. We can regard (1)lfdr  as the proportion of null 
component (1)0 ( )z   in total probability of observing (1)z . The posterior distribution of (2)Z  under 
1  is  (2) (1) * *21( , ,) ~|Z z N z  , where * (1) (2)ˆ /z    and  2* (1) (2)1 /     . Here
(1) 2
01/ (1 ( / ) )    plays a shrinkage effect. Then the Bayesian predictive power of the replication 
study is (details in the Supplementary Notes)  
 2
(1) *
/2(2)
*
( )( ),sgn z z z 
    (11) 
where ( )x  is the cumulative density function (cdf) of the standard normal distribution. 
When summary statistics of the primary study are available, we can approximate the asymptotic standard 
error of (2)ˆ  by substituting the observed allele frequencies from the primary study into Woolf’s method:  
 
(1) (1)
(2) 0 1
(2) (1) (1) (2) (1) (1)
0 00 01 1 10 11
1 1 1 1 .n n
n n n n n n
                (12) 
Clearly, RR, (1)lfdr  and (2)  depend on parameters 0  and 0 . Since we assume all SNPs share 
the same distribution structure in terms of effect size in Equation (9), we can estimate the parameters with 
the test statistics of the primary study. 
The estimation of 0  has been addressed in the literature of FDR control from the Bayesian point of 
view [21]. Suppose there is a “zero assumption” that all SNPs with p-value   have almost no chance to 
be truly associated SNPs. Let us denote the number of those SNPs as ( )m  . Then its expectation is  
 0( ( )) (1 ),E m m       (13) 
which introduces an 0  estimator  
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 0 ( )ˆ .(1 )
m
m
 
    (14) 
There is a tradeoff between bias and variance when choosing   in the estimation of 0 . Storey and 
Tibshirani [21] proposed a procedure without tuning the parameter  . The automated procedure will 
evaluate 0  at different  . Then, a natural cubic spline will fit to those evaluated values. We obtain the 
final 0  at 1   of the fitted spline. 
With the estimated 0 , we estimate 20  using the method of moments. The estimator of 20  reads 
(see Supplementary Notes for details)  
 
(1) 2
0
2 (1) 21
0
10
( )
ˆ max 0, / (1/ ) .(1 )
m
i m
i
i
i
z m
m

 


             
    (15) 
By plugging 0  and 20  into Eq. (7), (10) and (11), we obtain a RR estimator. For each primary 
association, we can use bootstrap method to obtain the confidence interval of RR. 
4  Applications of RR 
We will describe the two potential applications of RR in this subsection. 
4.1  Determine the sample size of the replication study 
Traditional sample size determination is based on power calculation. We need to specify a minimum 
detectable effect size ( min ) beforehand. Then, we determine the sample size such that the calculated 
statistical power is larger than a threshold, e.g., (2) ( ) 80%min   . This traditional power-based sample 
size determination method treats the primary study and the replication study separately. The connection 
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between the primary and replication studies is not utilized in the design. Also, the specified min  may be 
arbitrary, and bias may occur in the specification of min . These factors make the determined sample size 
subjective. 
In the design of a replication study, the main question we need to consider is how many primary 
associations will be replicated in the study with a given sample size? Power does not directly address this 
question. For example, (2) ( ) 80%min    doesn’t mean that 80% of primary associations can be 
replicated. We define the expected proportion of primary associations being validated in the replication 
study as the global replication rate (GRR), i.e.,  
 
2
(1) (2) (1)
/2GRR ( ( ) , ),|i i iP sgn z Z z z i S     (16) 
where 
1
(1)
/2{ | | }| iS i z z   is the index set of primary associations. We use the subscript i to denote the 
SNP index. GRR is a comprehensive measure directly addressing the question of replication. Also, the 
connection between the primary and replication studies is utilized in the GRR’s definition. It is more natural 
for us to determine the sample size of the replication study based on GRR. 
Clearly, there is a relationship between GRR and RR:  
 1GRR RR ,| | ii SS     (17) 
where |S| is the cardinality of S. Please note that RR is a monotonic increasing function of (2)n . After we 
set an expected replicability for primary associations, we can use the mean value of RR to determine the 
sample size needed in the replication study by the bisection method.  
4.2  Check the consistency between the results of the primary and replication studies 
After the replication study has been done, we can use RR to check the consistency between the results of 
the primary study and those of the replication study. Under normal situations, the results of the replication 
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study are consistent with RR values. If inconsistency occurs, we should be alarmed, and we need to analyze 
the potential sources of inconsistency. These sources may be attributed to factors influencing either the 
primary study’s or replication study’s results, such as bias and measurement errors [10]. 
We can use the Hosmer-Lemeshow test [13] to check the consistency. The detailed steps are as follows:  
1. We partition primary associations into groups according to RR. Each group has associations with 
approximately equal size. Let us take an example with 10 groups. The first group refers to 1/10 of 
the associations having the highest RR, while the second group refers to the next 1/10 of the 
associations having the second decile of RR, and so on.  
2. We call the proportion of the replicable associations in each group the group’s replication proportion 
(RP). We regard the mean value of RR as the group’s RR.  
3. We calculate the Hosmer-Lemeshow test statistic HL by comparing RP and RR in each group:  
 
2
1
(RP RR )HL ,RR (1 RR )
G
g g g
g g g
m

    (18) 
where G is the number of groups, g is the group index and gm  is the number of primary associations 
in group g.  
4. The null hypothesis is that the results of the replication study are consistent with the RR values. We 
compute the p-value using the parametric bootstrap method. That is, we resample the replication 
status for each primary association according to RR, and then we calculate HL again. This resampling 
trial is repeated R times. The p-value is the proportion of resampling trials in which HL is greater 
than or equal to the original HL value.  
5. If the p-value is smaller than the significance level, then we reject the null hypothesis. In other words, 
the results of the primary and the replication studies are inconsistent, and we need to analyze the 
potential sources of the inconsistency.  
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5  Software 
We create an R package called RRate, available at http://bioinformatics.ust.hk/RRate.html. The package 
contains the following functions:  
1. repRateEst(): to estimate the RR for each associations discovered from the primary study.  
2. repSampleSizeRR(): to determine the sample size of the replication study for a desired GRR value.  
3. HLtest(): to check the consistency between the results of the primary study and those of the 
replication study.  
We can use the following R code (repRateEst function) to estimate the RR in a simulation data set with 
10,000 SNPs and 4,000 individuals (2,000 controls and 2,000 cases) in the primary study. The sample size 
in the replication study is 2,000 (1,000 controls and 1,000 cases). The significance levels in two studies are 
65 10  and 35 10 , respectively. We use loose significance levels here because the number of SNPs in 
the example data set is small. We can use the repSampleSizeRR and HLtest functions to determine the 
sample size of the replication study and to check the consistency between the results of the primary and 
replication studies. 
1. library('RRate') 
2. alpha<‐5e‐6               #Significance level in the primary study 
3. alphaR<‐5e‐3              #Significance level in the replication study 
4. zalpha2<‐qnorm(1‐alpha/2) 
5. zalphaR2<‐qnorm(1‐alphaR/2) 
6.   
7. ##Load data 
8. data('smryStats1')       #Example summary statistics from the primary study 
9. n2.0<‐2000                #Number of individuals in control group 
10. n2.1<‐2000                #Number of individuals in case group 
11.  
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12. SE2<‐SEest(n2.0, n2.1, smryStats1$F_U, smryStats1$F_A) #SE in replication study 
13.   
14. ######  RR estimation  ###### 
15. RRresult<‐repRateEst(log(smryStats1$OR),smryStats1$SE, SE2,zalpha2,zalphaR2, 
output=T,dir='.') 
16. RR<‐RRresult$RR           #Estimated RR 
17.   
18. #### Sample size determination ### 
19. n1<‐4000                  #Sample size of the primary study 
20. n2_1<‐repSampleSizeRR(0.8, n1, log(smryStats1$OR),smryStats1$SE,zalpha2,zalphaR2) 
21.   
22. #### Hosmer‐Lemeshow test  #### 
23. data('smryStats2')       #Example summary statistics from the replication study 
24. sigIdx<‐(smryStats1$P<alpha) 
25. repIdx<‐(sign(smryStats1$Z[sigIdx])*smryStats2$Z[sigIdx]>zalphaR2) 
26. groupNum<‐10 
27. HLresult<‐HLtest(repIdx,RRresult$RR,g=groupNum,dir='.') 
6  Performance and applications of the RR with simulation and real data 
6.1  Simulation 
We use simulation experiments to answer the following questions:  
1. Can the estimated RR predict whether a primary association will be replicated or not?  
2. Is the estimated RR well calibrated as the replication probability?  
We simulate 5,000 controls and 5,000 cases in the primary study, and 2,500 controls and 2,500 cases in 
the replication study. The number of SNPs is 61 10 . The effect sizes of all SNPs are generated from the 
following two-component distribution:  
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 0~ 0.95 0.05 (0,0.04).N     (19) 
The minor allele frequencies are randomly simulated from a uniform distribution U(0.05,0.5), and the 
prevalence of the disease is set to 1%. We use 81 5 10    and 52 5 10    as significance levels in 
the primary study and replication study, respectively. Here we use a conservative significance level in the 
replication study just because we need a number of non-replicable associations to demonstrate the 
performance of the estimated RR. The method is applicable to any significance level. 
Figure 1 shows the comparison between RR and their true values. The two scatter plots show that RR 
work well in terms of estimation accuracy. This kind of experiment has been run 5 times. The root mean 
square error of RR in Table 2 show that RR have high estimation accuracy. We also present the estimated 
values of parameters ( 0  and 20 ) in this table. 
In order to see whether the estimated RR can predict the replication status well, we use RR as a score to 
predict whether the association can be replicated or not. We draw the receiver operator characteristic (ROC) 
curve (Figure 2a) using different thresholds in the prediction. A high RR value predicts that the association 
will be replicated. The area under the curve (AUC) is 0.858 in this simulation. This large area indicates that 
RR has good prediction performance as an index of replicability. In comparison, if we use the p-value as an 
index describing replicability, a low p-value predicts that the primary association is replicable. The AUC is 
0.848, smaller than the AUC of RR. Table 3 shows the comparison of AUC in each run. The AUC of RR is 
larger than the AUC of p-value. 
We use the group partition procedure (Step 1 and 2 in Subsection 4.2) to see whether the estimated RR 
calibrates the replication probability well. We partition the primary associations into 10 groups according 
to RR. Figure 2b shows a comparison between RR and RP for the 10 groups, and we can see that these two 
quantities agree well. The correlation between them is 0.999. This result implies RR is well calibrated as 
the replication probability. 
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We can use RR to determine the sample size needed in the replication study to achieve an expected 
replicability. Figure 3 plots the estimated GRR for different sample size ratios (2) (1)/n n  (from 0.5 to 1.5). 
For each sample size ratio, we simulate a dataset as the replication study. We call the realized proportion of 
primary associations being replicated the global replication proportion (GRP). We also plot GRP for 
different sample size ratios in Figure 3. From the figure, we can see that GRR and GRP agree well. If we 
want 80% of primary associations to be replicated, we need to collect about (1)0.5 5,000n   individuals 
in the replication study. 
We can also use RR to check the consistency between the results of the primary study and those of the 
replication study. We use the Hosmer-Lemeshow test to accomplish this task. The test statistic in this 
simulation experiment is 14.460, and the corresponding p-value is 0.105. The results of the primary and 
replication studies are therefore consistent. 
To check whether RR estimation has good performance in the phenotype with different genetic 
architecture, we also apply RR estimation to simulated data with different effect size distribution: 
 0~ 0.95 0.05 (0,0.0064)N   ，  (20) 
 0 5,0.2~ 0.95 0.05t   ，  (21) 
and 
 0~ 0.95 0.03 (0,0.0064)+0.02 (0,0.04)N N   ，  (22) 
  
where 5,0.2t  is a scaled t-distribution with degree of freedom 5 and scaling factor 0.2. In the first case, 
effect sizes of true associated SNPs are weak, which is a common case in a number of psychiatric disorders 
[22]. In the second case, effect sizes of associated SNPs follow heavy-tail distribution. In the third case, the 
distribution of associated SNPs’ effect sizes is a mixture of weak effect and strong effect. Figure 4 shows 
ROC curves and the RP-RR plot for three cases. Table 4 presents corresponding AUC values in each run. 
In the first case, prediction performances of RR and p-value are similar. In other two cases, RR performs 
better than p-value in terms of prediction. Calibration performances of RR are good in all three cases. The 
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well-calibration of RR implies that we can use RR to determine sample size of the replication study and to 
check the consistency between results of the primary and replication studies. 
To check the performance of RR estimation when independent assumption is violated, we use 
GWAsimulator [23] to generate genotype data of the individuals in the general population based on 
haplotype distributions from the HapMap CEU samples. We simulate m=314,174 SNPs which are on 
Illumina HumanHap300 chip, in which 15 of them are chosen as disease loci. For each disease loci, we use 
multiplicative model as disease model and the relative risk for heterozygotes is 2. We simulate 5,000 
controls and 5,000 cases in the primary study, and 2,500 controls and 2,500 cases in the replication study. 
Figure 5 shows ROC curves and the RP-RR plot. Table 5 presents AUC values in 5 runs. In this situation, 
RR has similar prediction performance to p-value. However, RR is well-calibrated as the replication 
probability.  
6.2  Real data 
6.2.1  T2D data from DIAGRAM 
We use the public T2D dataset from DIAGRAM (http://diagram-consortium.org/) to further check RR 
prediction and calibration performance. We use GWAS meta-analysis (DIAGRAMv3) as the primary study. 
There are 56,862 individuals in the control group and 12,171 individuals in the case group. The SNP number 
is m=2,468,203. We use metabochip meta-analysis as the replication study. The sample size in the control 
group is 58,119, and the sample size in the case group is 22,669. After filtering out SNPs with p-value<0.01 
in homogeneity test, there are 85,728 SNPs remaining in the replication study. We use the genome-wide 
significance level 81 5 10    in the primary study. And we use a stringent significance level 
5
2 5 10    in the replication study. The reason we use this stringent threshold is that we need a number 
of non-replicable associations to demonstrate the performance of the estimated RR. The method is 
applicable to any significance level. 
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The estimated proportion of null hypotheses is 0ˆ 0.964  , and the estimated effect size variance is
2 3
0ˆ 1.878 10   . There are 166 SNPs showing significant associations with T2D in the primary study 
and genotyped in the replication study. The GRP is 91.6%. We show the estimated RR results of these SNPs 
in Supplementary Table 1 (http://bioinformatics.ust.hk/RRate.html). The estimated GRR is 90.6%, which 
is very close to GRP. 
We draw the ROC curve for the prediction of replicability based on RR (Figure 6a). The AUC is 0.833. 
In comparison, if we use the p-value as an index predicting replicability, then the AUC is 0.762, smaller 
than the AUC of RR. 
In order to see whether the estimated RR is well-calibrated as the replication probability, we partition 
all primary associations into five groups according to their RR values. Then we make a comparison between 
RR and RP in each group. We use five groups here instead of the 10 groups used in the simulation study 
because the number of primary associations is much smaller than the number of associations in the 
simulation experiments. Figure 6b shows the comparison between RR and RP. These two quantities agree 
well, with the correlation between them being 0.986. This result illustrates that RR has a good calibration 
performance. 
We can use RR to determine the sample size of the replication study to achieve an expected number of 
replicable associations. We plot the estimated GRR for different sample size ratios (2) (1)/n n  (from 0.5 to 
1.0) in Figure 7. If we want 80% of primary associations to be replicated, we need about (1)0.9 62,130n   
individuals in the replication study. 
We can use the Hosmer-Lemeshow test to check the consistency between the results of the primary and 
replication studies. The test statistic is 1.559, and the corresponding p-value is 0.812. The results of the 
primary and replication studies are therefore consistent. 
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6.2.2  TC data from GLGC 
We also conducted experiments using published TC data from GLGC 
(http://csg.sph.umich.edu//abecasis/public/lipids2013/). The phenotype value measured in the study is 
quantitative, and we use the standardized regression coefficients as the test statistics. We use GWAS meta-
analysis, comprising 94,595 individuals, as the primary study. The SNP number is m=1,362,710. We use 
metabochip study, comprising 93,982 individuals, as the replication study. After filtering out SNPs with p-
value<0.01 in homogeneity test, there are 48,064 SNPs remaining in the replication study. The significance 
levels in the primary and replication studies are 85 10  and 55 10 , respectively. 
The estimated proportion of null hypotheses is 0ˆ 0.951  , and the estimated effect size variance is 
2 4
0ˆ 2.346 10   . There are 631 SNPs showing statistically significant associations with TC in the 
primary study and genotyped in the replication study. The GRP is 88.9%. We show the estimated RR results 
of these SNPs in Supplementary Table 2 (http://bioinformatics.ust.hk/RRate.html). The estimated GRR is 
89.9%, which is very close to GRP. 
We draw the ROC curve for the prediction of replicability based on RR (Figure 8a). The AUC is 0.871. 
In comparison, if we use the p-value as an index predicting replicability, then the AUC is 0.828, smaller 
than the AUC of RR. 
To see whether the estimated RR has good calibration performance, we partition the primary associations 
into five groups according to their estimated RR values. Then we make a comparison between RR and RP 
in each group. Figure 8b shows the good agreement between RR and RP in the five groups. The correlation 
coefficient is 0.993. 
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We can use RR to determine the sample size of the replication study, and we plot GRR for different 
sample size ratios (2) (1)/n n  in Figure 9. If we want 80% of primary associations to be replicated, we need 
about (1)0.76 71,892n   individuals in the replication study. 
We can use the Hosmer-Lemeshow test to check the consistency between the results of the primary and 
replication studies. The test statistic is 4.682, and the corresponding p-value is 0.29. The results of the 
primary and replication studies are therefore consistent. 
7  Discussion 
Please note that if (1)lfdr 0 , which is usually the case for a primary positive association, RR has an upper 
limit which is smaller than 1. According to Eq. (7),  
 
(1) (1) (2)
2
(1)
2
RR lfdr ( / 2) (1 lfdr )
1 lfdr (1 / 2),
 

  
     (23) 
where equality is achieved if (2) 1  . The influence of the null distribution (namely 2 / 2 ) never 
disappears for a primary positive association with (1)lfdr 0 . The Bayesian predictive power (2)  can 
be increased by increasing the sample size of the replication study. In the situation of (1)lfdr 0 , no matter 
how many individuals participate in the replication study, the primary association will not have 100% 
probability of being replicated. There is also an upper bound for GRR according to Eq. (17): 
 (1) 2
1GRR 1 lfdr (1 / 2)| | ii SS    .  (24) 
If 1  is stringent enough, (1)lfdr  is very small for each primary association. In this situation, the upper 
bounds of RR and GRR are close to 1. 
We normally use an unbiased testing method, i.e., (2)2 / 2  . Hence, we have (2)RR   according 
to Equation (7). This indicates that the probability of a primary association being replicated is smaller than 
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the Bayesian predictive power of the replication study. Normally, (1)lfdr  is controlled by using stringent 
significance level 1 , and 2  is a small value. RR and (2)  are close to each other in this situation. 
At first glance, one may regard the p-value as a quantitative index of replicability. A statistically 
significant association with a lower p-value has a higher possibility of being replicated than an association 
with a higher p-value. The argument is that the p-values of associations have the same ordering as the local 
false discovery rates, which are the probabilities of the corresponding hypotheses being true null hypotheses 
given their test statistics. But a low probability of being null hypotheses does not mean a high probability 
of being replicated. Hence, unlike RR, the p-value is not directly an index of replicability. 
Claiming an association to be replicated depends on the significance level of the replication study 2 . 
For primary associations, estimated RR values also depend on 2 . We present experiment results for 
4
2 5 10   and 62 5 10    on our website (http://bioinformatics.ust.hk/RRate.html). From Eq. (7) 
and (11), RR is a monotonic increasing function of 2 . This is consistent with our intuition: the more 
stringent threshold we set, the less primary associations will be replicated. 
RR also depends on parameters 0  and 20  among all SNPs. From Eq. (7) and (10), RR is a 
monotonic decreasing function of 0 . This is because the increase of 0  reduces the probability of each 
primary association being true associated one. From Eq. (7) (10) and (11), RR is a monotonic increasing 
function of 20 . This is because the decrease of 20  increases (1)lfdr  and decreases the power in the 
replication study. For diseases with weak effect sizes in associated SNPs, 20  is small and so is RR.  
 In some GWASs, the number of detected primary associations is small. This may be attributed to large 
value of 0  and/or small value of 20 . In either case with a given (2)n , RR is small. We need large 
sample size in the replication study to replicate primary associations with adequate RR. Since we use the 
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replication status of each primary association as an observation in our consistency checking method, there 
is no enough number of observations when only a few primary associations are detected. Hence, our 
consistency checking method has no enough power to detect inconsistency between results in this situation. 
The accuracy of RR estimation relies on the accuracy of 0ˆ . Although we apply the method of Storey 
and Tibshirani [21] to estimate 0 , there exist other options. For example, when the “zero assumption” is 
violated in data or the true null distribution of test statistics does not agree with the theoretical distribution 
[24], it may be better to use the methods proposed by Langaas et al. [25] or Jin and Cai [26] for a reliable 
estimation of 0 . 
Our method can be directly generalized to any tests within z-test scheme and with closed-form 
expression for standard error of effect size, such as log(OR) test, regression slope test and the Cochran-
Armitage trend test [27]. For other tests within z-test scheme but without closed-form expression for 
standard error of effect size, we have problem in estimating (2) . However, if control-to-case ratios are the 
same in the primary and replication studies, then we can approximate (2)  by the central limit theorem: 
 
(1)
(2) (1)
(2)
n
n
  . (25) 
In this case, we can use our method to estimate RR directly. 
The current model of RR is limited by the independence assumption between SNPs. In reality, 
correlations between SNPs, such as linkage disequilibrium, are common. An adjusted model for RR 
considering correlation is needed in the future. 
Our current model of RR is limited to z-test scheme in single-marker test. Recent developments in 
sequencing technique have extended targets of association studies to both common variants and rare variants. 
Single-marker test is underpowered in detecting rare variants. To deal with this issue, a lot of multi-marker 
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test and collapsing tests are proposed [28, 29]. Adjusted models for RR calculation with these testing 
methods are needed in the future.  
8  Conclusion 
In GWASs, statistically significant associations identified in a primary study need to be validated in a 
replication study. In this paper, we present a Bayesian framework to systematically study the behavior of 
those primary associations in the replication study. RR is a probabilistic measure to quantify that behavior. 
We describe an estimation method for RR based on the summary statistics of the primary study. We can 
use RR to determine the sample size of the replication study and to check the consistency between the results 
of the primary study and those of the replication study. We describe an R-package to estimate and apply 
RR in GWASs. Experiments using simulation and real data show the estimation results can accurately 
predict the replicability and is well calibrated. They also demonstrate the usefulness of RR. 
Funding 
This paper was partially supported by a theme-based research project T12-402/13N of the Hong Kong 
Research Grant Council (RGC). 
Acknowledgement 
Thanks to the Royal Academy of Engineering for a Research Exchanges with China Award to J.-H. Xue 
and W. Yu. We thank Prof. D. Donoho at Stanford University for insightful discussions. 
References 
[1] Hirschhorn JN and Daly MJ. Genome-wide association studies for common diseases and complex 
traits. Nature Reviews Genetics 2005;6(2):95-108. 
25 
 
[2] Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: 
practical considerations. Nature Reviews Genetics 2002;3(5):391-397. 
[3] Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 
1996;273(5281):1516-1517. 
[4] Klein RJ, Zeiss C, Chew EY et al.. Complement factor H polymorphism in age-related macular 
degeneration. Science 2005;308(5720):385-389. 
[5] Hindorff LA, MacArthur J, Morales J et al.. A catalog of published genome-wide association studies. 
http://www.genome.gov/gwastudies/ (28 May 2015, date last accessed). 
[6] Falk R. Replication-a step in the right direction commentary on Sohn. Theory & Psychology 
1998;8(3):313-321. 
[7] Blainey P, Krzywinski M, Altman N. Points of significance: replication. Nature Methods 
2014;11(9):879-880. 
[8] NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype–
phenotype associations. Nature 2007;447(7145):655-660. 
[9] Kraft P, Zeggini E, Ioannidis JP. Replication in genome-wide association studies. Statistical Science 
2009;24(4):561. 
[10] Ioannidis JP. Non-replication and inconsistency in the genome-wide association setting. Human 
Heredity 2006;64(4):203-213. 
[11] Open Science Collaboration. Estimating the reproducibility of psychological science. Science 
2015;349(6251):aac4716. 
[12]  Jaffe AE, Storey JD, Ji H et al.. Gene set bagging for estimating the probability a statistically 
significant result will replicate. BMC bioinformatics 2013;14(1):360. 
[13] Hosmer DW, Lemesbow S. Goodness of fit tests for the multiple logistic regression model. 
Communications in Statistics-Theory and Methods 1980;9(10):1043-1069. 
[14] Efron B. Local false discovery rates. Department of Statistics, Stanford University: Technical Report 
2005-20B, 2005. 
26 
 
[15] Morris AP, Voight BF, Teslovich TM et al.. Large-scale association analysis provides insights into 
the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics 2012;44(9):981. 
[16] Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. 
Nature Genetics 2013;45(11):1274-1283. 
[17] Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 
1955;19(4):251-253. 
[18] Lecoutre B. Bayesian predictive procedure for designing and monitoring experiments. Luxembourg: 
Bayesian Methods with Applications to Science, Policy and Official Statistics, 2001,301-310. 
[19] Yang J, Benyamin B, MeEvoy BP et al.. Common SNPs explain a large proportion of the heritability 
for human height. Nature Genetics 2010;42(7):565-569. 
[20] Park JH, Wacholder S, Gail MH et al.. Estimation of effect size distribution from genome-wide 
association studies and implications for future discoveries. Nature Genetics 2010;42(7):570-575. 
[21] Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proceedings of the National 
Academy of Sciences 2003;100(16):9440-9445. 
[22]  Collins, AL, Sullivan, PF. Genome-wide association studies in psychiatry: what have we learned?. 
The British Journal of Psychiatry 2013;202(1):1-4. 
[23] Li C, Li M. GWAsimulator: a rapid whole-genome simulation program. Bioinformatics 
2008;24(1):140-142. 
[24] Efron B. Large-scale simultaneous hypothesis testing: The choice of a null hypothesis. Journal of the 
American Statistical Association 2004;99:96-104. 
[25] Langaas M, Lindqvist BH, Ferkingstad E. Estimating the proportion of true null hypotheses, with 
application to DNA microarray data. Journal of the Royal Statistical Society: Series B (Statistical 
Methodology) 2005;67(4):555-572. 
[26] Jin J, Cai T. Estimating the null and the proportion of nonnull effects in large-scale multiple 
comparisons. Journal of the American Statistical Association 2007;102(478):495-506. 
27 
 
[27]  Cochran WG. Some methods for strengthening the common chi-squared tests. Biometrics 1954;10(4): 
417-451. 
[28]  Ionita-Laza I, Lee S, Makarov V et al.. Sequence kernel association tests for the combined effect of 
rare and common variants. The American Journal of Human Genetics 2013;92(6):841-853. 
[29]  Bansal V, Libiger O, Torkamani A et al.. Statistical analysis strategies for association studies 
involving rare variants. Nature Reviews Genetics 2010;11(11):773-785. 
  
28 
 
Key Points 
1. In GWAS, positive findings often need to be validated by replication studies.  
2. RR refers to the Bayesian probability of replicating a positive finding from the primary study.  
3. Before collecting the replication study, we can use RR to determine the sample size of the replication 
study.  
4. After the collection, we can use RR to check the consistency between the results of the primary study 
and those of the replication study.   
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Figures  
Figure 1: The estimation method can estimate RR accurately. The x-axis is the true values of RR in the 
simulation study, and the y-axis is the corresponding estimated values RR. The solid line is y = x. 
Figure 2: RR has good prediction and calibration performance in the simulation study. (a) We use RR and 
the p-value as scores to predict the replicated/non-replicated status in the replication study. We draw the 
corresponding ROC curves. The x-axis gives the false positive rate in the replicability prediction, and the 
y-axis gives the corresponding true positive rate. The AUC is the area under the ROC curve. RR has better 
prediction performance than the p-value. (b) We partition primary associations into 10 groups according to 
RR. The x-axis gives the RR of the group, which is the mean value of RR within the group. The y-axis gives 
the corresponding RP of the group, which is the proportion of the replicated associations in each group. The 
solid line is y=x. The correlation coefficient between RR and RP is 0.999. RR is well-calibrated.   
Figure 3: GRR and GRP for different sample size ratios (2) (1)/n n  in the simulation experiment. We 
estimate GRR using summary statistics from the primary study. For each sample size ratio, we simulate a 
dataset as the replication study. GRP is the realized proportion of primary associations being replicated. 
GRR and GRP agree well in the experiment.  
Figure 4: When effect sizes follow the distribution of Eq. (20), (21) and (22), the prediction and 
calibration performance of RR. (a) (c) (e) ROC curves of RR and p-value when effect sizes follow Eq. 
(20), (21) and (22), respectively. (b) (d) (f) RP-RR plot when effect sizes follow Eq. (20), (21) and (22), 
respectively. 
Figure 5: When we generate genotype data in the general population based on haplotype distributions from 
the HapMap CEU samples, the prediction and calibration performance of RR. (a) ROC curves of RR and 
p-value. (b) RP-RR plot.  
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Figure 6: RR has good prediction performance and is well calibrated in T2D data from DIAGRAM. (a) We 
draw both the ROC curve based on RR (solid line) and the ROC curve based on the p-value (dashed line) 
in the figure. According to their AUC values, RR predicts replicability better than the p-value. (b) We 
partition primary associations into five groups according to RR. The x-axis gives the RR of the group, which 
is the mean value of RR within the group. The y-axis gives the corresponding RP of the group, which is the 
proportion of the replicated associations in each group. The solid line is y=x. RR is well calibrated.  
Figure 7: GRR for different sample size ratios (2) (1)/n n  in T2D data from DIAGRAM. We use the 
summary statistics from the primary study to estimate GRR for different sample size ratios.  
Figure 8: RR has good prediction and calibration performance in TC data from GLGC. (a) We use RR and 
the p-value to predict the replication status of primary associations, respectively. We draw their ROC curves 
in the figure. According to their AUC values, RR has better prediction performance than the p-value. (b) 
We partition primary associations into five groups according to RR. The x-axis gives the RR of the group, 
and the y-axis gives the corresponding RP of the group. The solid line is y=x. RR is well calibrated.  
Figure 9: GRR for different sample size ratios (2) (1)/n n  in TC data from GLGC. We use the summary 
statistics from the primary study to estimate GRR for different sample size ratios.  
Tables 
Table 1: Contingency table of one SNP in study j. Please see the main text for explanation of the notations. 
Table 2: Root mean square error of RR in simulation experiments. We also present the estimated values of 
parameters ( 0  and 20 ) in this table. The true values of 0  and 20  are 0.95 and 0.04, respectively. 
Table 3: AUC values in simulation experiments. We use RR and p-value as an index describing replicability, 
respectively.  
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Table 4: AUC values in simulation experiments when effect sizes follow different distributions. Case 1: 
effect sizes follow the distribution of Eq. (20); Case 2: effect sizes follow the distribution of Eq. (21); Case 
3: effect sizes follow the distribution of Eq. (22). 
Table 5: AUC values when we generate genotype data in the general population based on haplotype 
distributions from the HapMap CEU samples. 
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 A a Total 
Control 𝑛00
(𝑗)
 𝑛01
(𝑗)
 2𝑛0
(𝑗)
 
Case 𝑛10
(𝑗)
 𝑛11
(𝑗)
 2𝑛1
(𝑗)
 
Total 𝑛00
(𝑗)
+ 𝑛10
(𝑗)
 𝑛01
(𝑗)
+ 𝑛11
(𝑗)
 2𝑛(𝑗) 
Table 1. Contingency table of one SNP in study j. Please see the main text for explanation of 
the notations. 
 RMSE of RR 0ˆ  
2
0ˆ  
run 1 0.005 0.958 0.047 
run 2 0.001 0.952 0.041 
run 3 0.004 0.957 0.047 
run 4 0.002 0.953 0.042 
run 5 0.002 0.953 0.043 
Table 2. Root mean square error (RMSE) of RR in simulation experiments. We also present the 
estimated values of hyperparameters ( 0  and 
2
0 ) in this table. The true values of 0  and 
2
0  are 0.95 and 0.04, respectively. 
 RR 𝑝-value 
run 1 0.858 0.848 
run 2 0.853 0.843 
run 3 0.856 0.847 
run 4 0.856 0.846 
run 5 0.858 0.849 
Average 0.856 0.847 
Table 3. AUC values in simulation experiments. We use RR and p-value as an index describing 
replicability, respectively. 
 Case 1 Case 2 Case 3 
RR 𝑝-value RR 𝑝-value RR 𝑝-value 
run 1 0.705 0.699 0.880 0.869 0.841 0.834 
run 2 0.602 0.603 0.884 0.874 0.846 0.839 
run 3 0.691 0.694 0.884 0.873 0.849 0.840 
run 4 0.643 0.639 0.882 0.871 0.845 0.841 
run 5 0.667 0.666 0.883 0.871 0.844 0.839 
Average 0.662 0.660 0.883 0.872 0.845 0.839 
Table 4. AUC values in simulation experiments when effect sizes follow different distributions. 
Case 1: effect sizes follow the distribution of Eq. (20); Case 2: effect sizes follow the 
distribution of Eq. (21); Case 3: effect sizes follow the distribution of Eq. (22). 
 RR 𝑝-value 
run 1 0.869 0.862 
run 2 0.822 0.826 
run 3 0.881 0.873 
run 4 0.834 0.831 
run 5 0.828 0.826 
Average 0.847 0.844 
Table 5: AUC values when we generate genotype data in the general population based on 
haplotype distributions from the HapMap CEU samples. 
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Supplementary Notes 
1  Detailed deduction of RR 
The relationship between RR, 
(1)lfdr  and 
(2) ( )   can be derived from the law of total probability:  
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2  Derivation of (1)lfdr , (2)  under a two-component mixture prior 
We need the following property for multivariate Gaussian distribution to calculate lfdr(1) and η(2).  
Property 1  If ~ ( , )| pNZ μ μ Σ , and ~ ( , )pN 0 0μ μ Σ , then  
 ~ ( , ) and ~ ( ( ) , ( ) )|p pN N   0 0 0Z μ Σ Σ μ z Wμ I W z I W Σ   (3) 
with 
1
0( )
   W . 
The proof of Property 2 can be found in Chapter 2 of [1]. 
By using Property 2, the distribution of the test statistic 
(1)Z  is  
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2 
Hence the local false discovery rate of the primary study can be calculated with the following:  
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where ( )x  is the pdf of the standard normal distribution. 
Since 
( ) ( ) 2ˆ( | ) ~ ( ,( ) )j jN     and 2
1 0( ) ~ (0, )| N  , we can obtain  
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 has a shrinkage effect. The posterior distribution of 
(2)Z  under 1  reads  
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The Bayesian predictive power of the replication study can be calculated as follows:  
 2
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where ( )x  is the cdf of the standard normal distribution. 
3  Derivation of the 20  estimator 
From (4), the distribution of 
(1)Z  is a two-component Gaussian mixture model. So we have  
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where 
2
1  is the 
2  distribution with degree of freedom (df) 1. The expectation reads  
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For all SNPs, the following can be obtained:  
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